TW200640922A - Pharmaceutical compounds - Google Patents
Pharmaceutical compoundsInfo
- Publication number
- TW200640922A TW200640922A TW095101705A TW95101705A TW200640922A TW 200640922 A TW200640922 A TW 200640922A TW 095101705 A TW095101705 A TW 095101705A TW 95101705 A TW95101705 A TW 95101705A TW 200640922 A TW200640922 A TW 200640922A
- Authority
- TW
- Taiwan
- Prior art keywords
- compounds
- kinases
- pharmaceutical compounds
- activity
- novel
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to pyrazole compounds that inhibit or modulate the activity of Cyclin Dependent Kinase (CDK) and Glycogen Synthase Kinases (GSK) kinases, to the use of the compounds in the treatment or prophylaxis of disease states or conditions mediated by the kinases, and to novel compounds having kinase inhibitory or modulating activity. Also provided are pharmaceutical compositions containing the compounds and novel chemical intermediates.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64621705P | 2005-01-21 | 2005-01-21 | |
GB0501480A GB0501480D0 (en) | 2005-01-22 | 2005-01-22 | Pharmaceutical compounds |
GB0501748A GB0501748D0 (en) | 2005-01-27 | 2005-01-27 | Pharmaceutical compounds |
US65133905P | 2005-02-09 | 2005-02-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200640922A true TW200640922A (en) | 2006-12-01 |
Family
ID=45699652
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW095101705A TW200640922A (en) | 2005-01-21 | 2006-01-17 | Pharmaceutical compounds |
TW095101695A TW200637858A (en) | 2005-01-21 | 2006-01-17 | Pharmaceutical compounds |
TW095101704A TW200639170A (en) | 2005-01-21 | 2006-01-17 | Pharmaceutical compounds |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW095101695A TW200637858A (en) | 2005-01-21 | 2006-01-17 | Pharmaceutical compounds |
TW095101704A TW200639170A (en) | 2005-01-21 | 2006-01-17 | Pharmaceutical compounds |
Country Status (3)
Country | Link |
---|---|
GT (3) | GT200600016A (en) |
MY (1) | MY139848A (en) |
TW (3) | TW200640922A (en) |
-
2006
- 2006-01-11 GT GT200600016A patent/GT200600016A/en unknown
- 2006-01-11 GT GT200600014A patent/GT200600014A/en unknown
- 2006-01-11 GT GT200600015A patent/GT200600015A/en unknown
- 2006-01-17 TW TW095101705A patent/TW200640922A/en unknown
- 2006-01-17 TW TW095101695A patent/TW200637858A/en unknown
- 2006-01-17 TW TW095101704A patent/TW200639170A/en unknown
- 2006-01-18 MY MYPI20060218 patent/MY139848A/en unknown
Also Published As
Publication number | Publication date |
---|---|
MY139848A (en) | 2009-11-30 |
GT200600014A (en) | 2006-08-09 |
GT200600015A (en) | 2006-08-09 |
TW200637858A (en) | 2006-11-01 |
TW200639170A (en) | 2006-11-16 |
GT200600016A (en) | 2006-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006106326A8 (en) | Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors | |
WO2006083673A3 (en) | Pyridine derivatives useful as inhibitors of c-jun n-terminal kinases | |
WO2007079164A3 (en) | Protein kinase inhibitors | |
GEP20135785B (en) | Pyrrolopyrimidine compounds as cdk inhibitors | |
MX2009006535A (en) | Indol-4-yl-pyrimidinyl-2-yl-amine derivatives and use thereof as cyclin dependant kinase inhibitors. | |
MX2010006203A (en) | Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases. | |
MX2009002377A (en) | Indazole derivatives as modulators of interleukin- 1 receptor-associated kinase. | |
GEP20135724B (en) | Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for treatment or prevention of diabetes | |
GEP20125368B (en) | Kinase inhibitors | |
WO2006055831A3 (en) | Kinase inhibitors | |
WO2007109045A8 (en) | Heterocyclic organic compounds for the treatment of in particular melanoma | |
MX2009003734A (en) | Pyrazolopyrimidiwes as cyclin dependent kinase inhibitor. | |
WO2011090738A3 (en) | Type ii raf kinase inhibitors | |
WO2008049123A8 (en) | 2,4-pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases | |
WO2007067781A3 (en) | 9-membered heterobicyclic compounds as inhibitors of protein kinases | |
EP1841770A4 (en) | Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes | |
EP2571876A4 (en) | Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes | |
TN2009000128A1 (en) | Dihydropyridine derivatives useful as protein kinase inhibitors | |
MXPA06010904A (en) | Tricyclic pyrazole kinase inhibitors. | |
MXPA05005199A (en) | Pyrimidine compounds. | |
WO2006050109A3 (en) | Novel kinase inhibitors | |
WO2006063302A3 (en) | Variants of glycogen synthase kinase 3 and uses thereof | |
WO2009097287A9 (en) | Compounds and compositions as kinase inhibitors | |
MX2009010047A (en) | Chemical compounds. | |
MY149044A (en) | Pyrazolopyrimidines - derivatives as cyclin dependent kinase inhibitors |